ArticleBioMed research international2018
Multiple Hidden Markov Model for Pathological Vessel Segmentation.
Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the obstacles that prevent the accurate delineation of vessel boundaries is the presence of pathologies, which results in obscure boundaries and vessel-like structures. Targeting this limitation, we present a novel segmentation method based on multiple Hidden Markov Models. This method works with a vessel axis + cross-section model, which constrains the classifier around the vessel. The vessel axis constraint gives our method the potential to be both physiologically accurate and computationally effective. Focusing on pathological vessels, we reap the benefits of the redundant information embedded in multiple vessel-specific features and the good statistical properties coming with Hidden Markov Model, to cover the widest possible spectrum of complex situations. The performance of our method is evaluated on synthetic complex-structured datasets, where we achieve a 91% high overlap ratio. We also validate the proposed method on a real challenging case, segmentation of pathological abdominal arteries. The performance of our method is promising, since our method yields better results than two state-of-the-art methods on both synthetic datasets and real clinical datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.